NEW YORK – From a business perspective, 2021 was perhaps proteomics' biggest year on record as a number of firms in the space went public, many of them at $1 billion-plus valuations.
It remains to be seen whether this flurry of commercial activity will lead to substantial improveme
Your Go To News Portal
The report published by In4Research on NEOPENTYL GLYCOL MONO(HYDROXYPIVALATE) CAS 1115-20-4 Market is the most reliable information source as the study relies on a specific research methodology that focuses on both primary and secondary sources. The primary source,
Your Go To News Portal
Get Sample Report Buy Complete Report
4-Hexen-3-One Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top playe
Covering the impact of coronavirus on the sports world
The NFL has been incredibly unpredictable over the past two weeks due to COVID-19, but th
© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
Treatment Innovations in Waldenstrom Macroglobulinemia - Episode 4
What pharmacists need to know about the adoption of novel targeted ther
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
SHANGHAI , Dec. 14, 2021 /PRNewswire/ -- Honeywell (Nasdaq: HON) today announced Solstice Propellant, a solution based on breakthrough next-generation hydrofluoroolefin (HFO) technology, completed registration for new cosmetic raw materials by China's National Medical Products Administration
Three Federal Emergency Management Agency teams will be heading to New Hampshire next week to help administer monoclonal antibody therapy for COVID-19 at hospitals in the state.
Gov. Chris Sununu announced Wednesday that the state has received confirmation that FEMA monoclonal antibody t
RANCHO CUCAMONGA, CA / ACCESSWIRE / December 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has tentatively approved the Company's Abbreviated New Drug Application ("ANDA") for Vasopressin injection, USP
Due to our modern society’s emphasis on processed foods, little exercise, and stress-filled lifestyles, leaky gut syndrome has become a very common health condition and the root of many health problems, including food sensitivities, mood issues, autoimmune diseases, and chronic exhaustion. <
